查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年數位呼吸設備市場預測：按產品、疾病、配銷通路、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1383407

到 2030 年數位呼吸設備市場預測：按產品、疾病、配銷通路、最終用戶和地區進行的全球分析

Digital Respiratory Devices Market Forecasts to 2030 - Global Analysis By Product, Disease, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球數位呼吸設備市場規模為 465 億美元，預計預測期內年複合成長率為 27.5%，到 2030 年將達到 2,549 億美元。

數位呼吸設備是一個醫療保健領域，涉及開發和利用數位技術來監測和管理呼吸系統疾病。這些設備旨在幫助診斷、治療和持續管理氣喘、慢性阻塞性肺病(COPD) 和其他呼吸系統疾病等疾病。應用包括即時監測肺功能、追蹤用藥醫囑遵從性和遠端系統管理。

根據世界衛生組織（WHO）預測（2020年），到2030年，慢性阻塞性肺病將超過缺血性心臟疾病和愛滋病毒/愛滋病，成為第四大死因。

呼吸道疾病盛行率增加

氣喘、慢性阻塞性肺病( COPD) 和睡眠呼吸中止疾病呈上升趨勢，推動了對監測、管理和改善呼吸系統健康的創新解決方案的需求。數位呼吸設備提供即時監測、資料收集和個體化治療計劃，使患者和醫療保健提供者能夠有效解決這些問題。隨著呼吸系統疾病的負擔變得更加突出，這些設備在加強患者照護、早期療育和自我管理方面發揮關鍵作用，最終改善受這些疾病影響的人們的生活品質，並促進市場成長。

與現有醫療保健系統的兼容性和整合

醫療保健系統通常使用各種電子健康記錄(EHR) 和資料管理平台，這些平台可能不容易容納新的數位呼吸設備或與新的數位呼吸設備通訊。缺乏互通性阻礙了患者資料的無縫交換，並使醫療保健提供者難以將設備生成的資訊涵蓋患者記錄和治療計劃中。為了克服這一限制，標準化的資料格式、改進的通訊協定以及數位呼吸設備與現有醫療保健系統的無縫整合將實現更有效的患者照護和資料主導，需要配合措施才能做到這一點。

遠端醫療和遠端患者監護技術的發展

這些技術在醫療保健領域已變得至關重要，可提供呼吸道疾病的即時遠端監測。數位呼吸設備能夠很好地利用這一趨勢，為患者提供一種檢測重要呼吸資料並將其傳輸給醫療保健提供者的方法，從而促進遠端諮詢和主動護理。這不僅增加了患者的便利性，還改善了病情加重的早期檢測並支持個人化治療計劃。將數位呼吸設備整合到遠距醫療平台中符合不斷發展的醫療保健形勢，提供以患者為中心的方法，並擴大改善呼吸護理的市場潛力。

資料隱私和安全問題

收集和傳輸敏感的患者健康資料會增加資料外洩和詐欺存取的風險，這可能對患者隱私產生嚴重影響。法規和強力的網路安全措施對於保護這些資料至關重要。資料外洩和資料濫用的威脅可能會破壞患者的信任並阻礙數位呼吸設備的採用。為了克服這項威脅，需要採取嚴格的資料保護措施、加密協定和全面的資料安全策略，確保病患資訊的隱私和安全性，並維持數位呼吸醫療解決方案的完整性。

COVID-19 的影響：

COVID-19 的疫情對市場產生了重大影響。呼吸健康已成為全球關注的前沿問題，對包括數位呼吸設備在內的遠端監控和遠端醫療解決方案的需求激增。這些設備使醫療保健提供者能夠遠端監控和管理呼吸狀況，同時最大限度地減少面對面接觸並降低病毒傳播的風險。這場大流行加速了這些技術的採用，使其成為醫療保健生態系統的重要組成部分。此外，大流行期間對呼吸健康的關注提高了醫療保健提供者和患者對數位呼吸設備的認知和接受度。

霧化器市場預計將在預測期內成為最大的市場

霧化器領域預計將出現良好的成長。這些設備廣泛用於治療各種呼吸系統疾病，包括氣喘和慢性阻塞性肺病（COPD）。數位霧化器具有精確的給藥傳遞、增強的攜帶性以及用於遠端監測和治療調整的資料連接等優點。使患者能夠更有效地管理他們的呼吸健康，提高用藥醫囑遵從性，並使醫療保健提供者能夠遠端監控治療依從性。數位霧化器有助於改善患者的治療效果並減輕呼吸系統疾病的負擔，從而推動市場的採用。

醫院部門預計在預測期內年複合成長率最高

預計醫院產業在預測期內將以最快的年複合成長率成長。這些醫療機構依靠數位呼吸設備對患有氣喘、慢性阻塞性肺病(COPD) 和睡眠呼吸中止呼吸系統症候群的患者進行準確診斷、監測和治療。數位呼吸設備透過提供有關肺功能、藥物醫囑遵從性和治療效果的即時資料來增強患者護理。這使得醫療保健專業人員能夠做出資訊的決定並快速調整治療計劃。在醫院使用這些設備不僅可以改善患者的治療效果，還有助於提高呼吸護理的整體效率和質量，使其成為醫療保健生態系統的重要組成部分。

比最大的地區

預計北美市場在預測期內將繼續佔據大部分市場佔有率。該地區由美國和加拿大組成，高齡化、環境因素和文明病導致呼吸道疾病負擔日益增加。數位呼吸設備已在北美廣泛採用，為監測、診斷和管理這些疾病提供了先進的解決方案。此外，該地區對遠端醫療和遠端監控技術的投資正在加速數位呼吸設備融入醫療保健生態系統。北美因其對創新和卓越醫療保健的承諾而成為全球數位呼吸設備市場的主要驅動力。

複合年複合成長率最高的地區：

預計亞太地區在預測期內複合年複合成長率最高。在中國和印度等國家，人口不斷成長，呼吸道疾病的盛行率也增加。該地區正在對醫療基礎設施進行大量投資，並採用數位醫療技術，包括數位呼吸設備。這些設備使醫療保健提供者能夠接觸到更多的患者群體並更好地管理呼吸系統疾病，特別是在偏遠地區。此外，亞太地區專注於遠端醫療、遠端患者監護和個人化醫療，被定位為一個充滿活力且不斷擴大的數位呼吸設備市場，為改善呼吸照護和患者治療效果提供了巨大潛力。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球數位呼吸設備市場：按產品

  • 呼吸消耗品
    • 呼吸面罩
    • 氧氣鼻管
    • 氧氣管組
    • 呼吸過濾器
  • 噴霧器
    • 壓縮噴射霧化器
    • 超音波霧化器
    • 其他霧化器
  • 氧氣濃縮機
    • 家用氧氣濃縮機
    • 攜帶式氧氣濃縮機
  • 正壓呼吸器(PAP)設備
  • 睡眠多項生理檢查
  • 門診 PSG 設備
  • 臨床PSG裝置
  • 脈搏血氧儀
  • 人工呼吸器
  • 肺活量計
  • 其他產品

第6章 全球數位呼吸設備市場：依疾病分類

  • 氣喘
  • 慢性阻塞性肺病（COPD）
  • 其他疾病

第7章 全球數位呼吸設備市場：按配銷通路

  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 其他配銷通路

第8章 全球數位呼吸設備市場：依最終用戶分類

  • 醫院
  • 居家照護環境
  • 其他最終用戶

第9章 全球數位呼吸設備市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • 3M Health Care Limited
  • Adherium Limited
  • AireHealth, Inc.
  • Amiko Digital Health Limited
  • Cognita Labs
  • COHERO Health Inc.
  • FindAir Sp. z oo
  • Novartis AG
  • Pneuma Respiratory Inc.
  • Propeller Health
  • Teva Pharmaceuticals Industries Ltd.
Product Code: SMRC24256

According to Stratistics MRC, the Global Digital Respiratory Devices Market is accounted for $46.5 billion in 2023 and is expected to reach $254.9 billion by 2030 growing at a CAGR of 27.5% during the forecast period. The Digital Respiratory Devices is the healthcare sector involving the development and utilization of digital technologies to monitor and manage respiratory conditions. These devices are designed to assist in the diagnosis, treatment, and ongoing management of diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. Their uses include real-time monitoring of lung function, medication adherence tracking, and remote patient management.

According to the World Health Organization prediction (2020), COPD will surpass ischemic heart disease and HIV/AIDS to become the fourth-leading causes of death, respectively, by 2030.

Market Dynamics:

Driver:

Increasing prevalence of respiratory diseases

Conditions like asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea are on the rise, leading to a growing need for innovative solutions to monitor, manage, and improve respiratory health. Digital respiratory devices offer real-time monitoring, data collection, and personalized treatment plans, empowering patients and healthcare providers to effectively address these conditions. With the burden of respiratory diseases becoming more pronounced, these devices play a vital role in enhancing patient care, early intervention, and self-management, ultimately improving the quality of life for individuals affected by such conditions and driving market growth.

Restraint:

Compatibility and integration with existing healthcare systems

Health systems often use various electronic health records (EHR) and data management platforms, which may not readily accommodate or communicate with new digital respiratory devices. This lack of interoperability hinders the seamless exchange of patient data, making it difficult for healthcare providers to incorporate device-generated information into patient records and treatment plans. Overcoming this restraint requires standardized data formats, improved communication protocols, and collaborative efforts to ensure that digital respiratory devices can seamlessly integrate with existing healthcare systems, enabling more effective patient care and data-driven interventions.

Opportunity:

Growth of telehealth and remote patient monitoring technologies

These technologies have become integral in healthcare, offering real-time remote monitoring of respiratory conditions. Digital respiratory devices are well-positioned to leverage this trend by providing patients with the means to measure and transmit vital respiratory data to healthcare providers, facilitating remote consultations and proactive care. This not only enhances patient convenience but also improves early detection of exacerbations and supports personalized treatment plans. The integration of digital respiratory devices into telehealth platforms aligns with the evolving healthcare landscape, offering a patient-centric approach and expanding the market's potential for improved respiratory care.

Threat:

Data privacy and security concerns

With the collection and transmission of sensitive patient health data, there is an increased risk of data breaches and unauthorized access, which can have serious consequences for patient privacy. Regulatory compliance and robust cybersecurity measures are paramount to safeguarding this data. The threat of breaches or data misuse can erode patient trust and hinder the adoption of digital respiratory devices. Overcoming this threat requires stringent data protection measures, encryption protocols, and comprehensive data security strategies to ensure patient information remains confidential and secure, thereby preserving the integrity of digital respiratory healthcare solutions.

COVID-19 Impact:

The COVID-19 pandemic had a significant impact on the market. With respiratory health at the forefront of global concerns, the demand for remote monitoring and telehealth solutions, including digital respiratory devices, surged. These devices allowed healthcare providers to remotely monitor and manage respiratory conditions while minimizing in-person contact, reducing the risk of virus transmission. The pandemic accelerated the adoption of these technologies, making them an essential component of the healthcare ecosystem. Additionally, they focus on respiratory health during the pandemic created greater awareness and acceptance of digital respiratory devices among both healthcare providers and patients.

The nebulizers segment is expected to be the largest during the forecast period

The nebulizers segment is expected to have a lucrative growth. These devices are widely used for treating various respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). Digital nebulizers offer advantages such as precise dosage delivery, enhanced portability, and data connectivity for remote monitoring and treatment adjustment. They empower patients to manage their respiratory health more effectively, improve medication adherence, and enable healthcare providers to monitor treatment compliance remotely. Digital nebulizers are instrumental in enhancing patient outcomes and reducing the burden of respiratory diseases, driving their adoption in the market.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period. These healthcare facilities rely on digital respiratory devices for the precise diagnosis, monitoring, and treatment of patients with respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Digital respiratory devices enhance patient care by providing real-time data on lung function, medication adherence, and treatment effectiveness. They enable healthcare professionals to make informed decisions and adjust treatment plans promptly. The use of these devices in hospitals not only improves patient outcomes but also contributes to the overall efficiency and quality of respiratory care, making them integral components of the healthcare ecosystem.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. The region comprises the United States and Canada, where an aging population, environmental factors, and lifestyle-related conditions contribute to the growing burden of respiratory ailments. Digital respiratory devices are widely adopted in North America, offering advanced solutions for monitoring, diagnosing, and managing these conditions. Moreover, the region's investment in telehealth and remote monitoring technologies has accelerated the integration of digital respiratory devices into the healthcare ecosystem. North America's commitment to innovation and healthcare excellence positions it as a key driver in the global digital respiratory devices market.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. With a vast and growing population, there is an increasing prevalence of respiratory diseases in countries like China and India. The region is witnessing significant investments in healthcare infrastructure and the adoption of digital health technologies, including digital respiratory devices. These devices enable healthcare providers to reach a wider patient base, especially in remote areas, and enhance the management of respiratory conditions. Moreover, the Asia Pacific's focus on telehealth, remote patient monitoring, and personalized healthcare positions it as a dynamic and expanding market for digital respiratory devices, offering significant potential for improving respiratory care and patient outcomes.

Key players in the market

Some of the key players in Digital Respiratory Devices market include: 3M Health Care Limited, Adherium Limited, AireHealth, Inc., Amiko Digital Health Limited, Cognita Labs, COHERO Health Inc., FindAir Sp. z o.o, Novartis AG, Pneuma Respiratory Inc., Propeller Health and Teva Pharmaceuticals Industries Ltd.

Key Developments:

In February 2023, Adherium Limited, a market leader in respiratory eHealth, remote monitoring, and data management, announced that the FDA's 510(k) approval has allowed it to begin selling its first, next-generation Hailie Sensor, which includes physiological measures for tracking the use of asthma and COPD medications.

In September 2022, Propeller Health expanded their pharmacy refill app to cover CVS, Rite-Aid, Kroger, and Walmart pharmacies.

In July 2022, Propeller Health also launched My Drugstore, an in-app service in collaboration with Walgreens that allows clients to manage their medication refills for COPD and asthma and locate a nearby pharmacy.

Products Covered:

  • Respiratory Consumables
  • Nebulizers
  • Oxygen Concentrators
  • Positive Airway Pressure (PAP) Devices
  • Polysomnography Devices
  • Ambulatory PSG Devices
  • Clinical PSG Devices
  • Pulse Oximeters
  • Mechanical Ventilators
  • Spirometers
  • Other Products

Diseases Covered:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Other Diseases

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels

End Users Covered:

  • Hospitals
  • Homecare Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Respiratory Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Respiratory Consumables
    • 5.2.1 Respiratory Mask
    • 5.2.2 Nasal Cannulas
    • 5.2.3 Oxygen Tubing Sets
    • 5.2.4 Breathing Filters
  • 5.3 Nebulizers
    • 5.3.1 Compressed Jet Nebulizers
    • 5.3.2 Ultrasonic Nebulizers
    • 5.3.3 Other Nebulizers
  • 5.4 Oxygen Concentrators
    • 5.4.1 Home Oxygen Concentrators
    • 5.4.2 Portable Oxygen Concentrators
  • 5.5 Positive Airway Pressure (PAP) Devices
  • 5.6 Polysomnography Devices
  • 5.7 Ambulatory PSG Devices
  • 5.8 Clinical PSG Devices
  • 5.9 Pulse Oximeters
  • 5.10 Mechanical Ventilators
  • 5.11 Spirometers
  • 5.12 Other Products

6 Global Digital Respiratory Devices Market, By Disease

  • 6.1 Introduction
  • 6.2 Asthma
  • 6.3 Chronic Obstructive Pulmonary Disease (COPD)
  • 6.4 Other Diseases

7 Global Digital Respiratory Devices Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Retail Pharmacies
  • 7.4 Online Pharmacies
  • 7.5 Other Distribution Channels

8 Global Digital Respiratory Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Homecare Settings
  • 8.4 Other End Users

9 Global Digital Respiratory Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 3M Health Care Limited
  • 11.2 Adherium Limited
  • 11.3 AireHealth, Inc.
  • 11.4 Amiko Digital Health Limited
  • 11.5 Cognita Labs
  • 11.6 COHERO Health Inc.
  • 11.7 FindAir Sp. z o.o
  • 11.8 Novartis AG
  • 11.9 Pneuma Respiratory Inc.
  • 11.10 Propeller Health
  • 11.11 Teva Pharmaceuticals Industries Ltd.

List of Tables

  • Table 1 Global Digital Respiratory Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Digital Respiratory Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Digital Respiratory Devices Market Outlook, By Respiratory Consumables (2021-2030) ($MN)
  • Table 4 Global Digital Respiratory Devices Market Outlook, By Respiratory Mask (2021-2030) ($MN)
  • Table 5 Global Digital Respiratory Devices Market Outlook, By Nasal Cannulas (2021-2030) ($MN)
  • Table 6 Global Digital Respiratory Devices Market Outlook, By Oxygen Tubing Sets (2021-2030) ($MN)
  • Table 7 Global Digital Respiratory Devices Market Outlook, By Breathing Filters (2021-2030) ($MN)
  • Table 8 Global Digital Respiratory Devices Market Outlook, By Nebulizers (2021-2030) ($MN)
  • Table 9 Global Digital Respiratory Devices Market Outlook, By Compressed Jet Nebulizers (2021-2030) ($MN)
  • Table 10 Global Digital Respiratory Devices Market Outlook, By Ultrasonic Nebulizers (2021-2030) ($MN)
  • Table 11 Global Digital Respiratory Devices Market Outlook, By Other Nebulizers (2021-2030) ($MN)
  • Table 12 Global Digital Respiratory Devices Market Outlook, By Oxygen Concentrators (2021-2030) ($MN)
  • Table 13 Global Digital Respiratory Devices Market Outlook, By Home Oxygen Concentrators (2021-2030) ($MN)
  • Table 14 Global Digital Respiratory Devices Market Outlook, By Portable Oxygen Concentrators (2021-2030) ($MN)
  • Table 15 Global Digital Respiratory Devices Market Outlook, By Positive Airway Pressure (PAP) Devices (2021-2030) ($MN)
  • Table 16 Global Digital Respiratory Devices Market Outlook, By Polysomnography Devices (2021-2030) ($MN)
  • Table 17 Global Digital Respiratory Devices Market Outlook, By Ambulatory PSG Devices (2021-2030) ($MN)
  • Table 18 Global Digital Respiratory Devices Market Outlook, By Clinical PSG Devices (2021-2030) ($MN)
  • Table 19 Global Digital Respiratory Devices Market Outlook, By Pulse Oximeters (2021-2030) ($MN)
  • Table 20 Global Digital Respiratory Devices Market Outlook, By Mechanical Ventilators (2021-2030) ($MN)
  • Table 21 Global Digital Respiratory Devices Market Outlook, By Spirometers (2021-2030) ($MN)
  • Table 22 Global Digital Respiratory Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 23 Global Digital Respiratory Devices Market Outlook, By Disease (2021-2030) ($MN)
  • Table 24 Global Digital Respiratory Devices Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 25 Global Digital Respiratory Devices Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 26 Global Digital Respiratory Devices Market Outlook, By Other Diseases (2021-2030) ($MN)
  • Table 27 Global Digital Respiratory Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 28 Global Digital Respiratory Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 29 Global Digital Respiratory Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 30 Global Digital Respiratory Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 31 Global Digital Respiratory Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 32 Global Digital Respiratory Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 Global Digital Respiratory Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 34 Global Digital Respiratory Devices Market Outlook, By Homecare Settings (2021-2030) ($MN)
  • Table 35 Global Digital Respiratory Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.